Why I built this
I spend my days understanding why innovative medicines don't reach the patients who need them — navigating pricing, market access, and the systems that determine who gets treated.
This initiative started from a simple realization: a vaccine that can protect girls from cervical cancer already exists. Girls in underserved communities across Maharashtra don't have access to it — not because of science, but because of last-mile gaps that funding and coordination can close.
India's government has launched a national HPV campaign and we are proud to extend its reach — ensuring girls aged 9–14 in high-need communities are not left behind.